The presence of D-2-HG in IDH1/2 mutated gliomas induced inhibition of KDM4A, which decreases the half-life and protein level of DEPTOR, and further enhances mTORC1/2 kinase activities [95]. This evidence concerns the gene IDH1 and central nervous system cancer.